Change in the Management of TSS

The TSS company logo, representing a change in the company's management.
We are thrilled to announce a new chapter at TSS as we bid farewell to our esteemed CEO, Niclas Ohlsson.

After 16 years of dedicated service as our Chief Executive Officer (CEO), Niclas Ohlsson has made the decision to step down to prioritize his well-being following a recent health scare. Niclas has been instrumental in shaping TSS into a leading company within the industry, and we are truly grateful for his years of hard work and leadership.

Stepping into the role of CEO is Tobias Holmer, our CTO for the past 9 years and interim CEO for the last 7 months. Tobias's wealth of experience and forward-thinking leadership have already positively impacted our organization, and we are enthusiastic about the exciting future under his guidance.

We are excited to continue our mission of delivering the highest standards in temperature monitoring solutions for the pharmaceutical industry.

Join us in wishing Niclas all the best in his future endeavors and thanking him for his remarkable contributions. Here’s to a new era of growth and success with Tobias at the helm!

__wf_reserved_inherit
Tobias Holmer, CEO

You may also be interested in

An image for NECSO Cambridge 2023, with the words "Clinical Trial" on a high-tech interface.

NECSO Cambridge 2023

Where do the majority of your temperature excursions occur? Why not eliminate them?
Read moreDownload Whitepaper
A scientist using a tablet in a modern laboratory.

On-demand webinar: New approaches to automating temperature management in clinical trials

Temperature excursion management is a prime example of a clinical process that automation can make more efficient. It is currently a highly burdensome activity, where every temperature excursion is evaluated regardless of how minor they are and if they fit well within the excursion budget.
Read moreDownload Whitepaper

Reducing excursion evaluation time from days to seconds

The question of how to speed up clinical trials is complicated, especially considering that many trial stages simply cannot be rushed in the interest of trial subjects and the general public. However, process improvements can go a long way.
Read moreDownload Whitepaper

You may also be interested in

What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?

The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more
A view of Earth from space at night, representing the global reach of TSS's new BLE technology for temperature monitoring.

On-demand webinar: Introducing BLE technology for temperature monitoring

Get introduced to the solution tailored to GxP critical shipments – BLE technology for temperature monitoring
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.